A Pilot Study to Identify Biomarkers Associated With Chronic Traumatic Brain Injury

The University of Texas Health Science Center, Houston96 enrolled

Overview

The aim of this research is to determine if the biological fluids (blood/saliva) from chronic brain-injured patients (both blast and non-penetrating TBI) contain reproducible protein markers. To accomplish this two populations of chronic TBI patients who are receiving treatment at The Institute for Research and Rehabilitation (TIRR): blast injury victims and non-penetrating TBI will be studied. Using multiple proteomic approaches including mass spectrometry, multiplex ELISAs, and antibody microarrays, as well as RNA profiling, the investigators aim to identify biomarkers in the blood/saliva of patients suffering from chronic TBI and to determine the similarities/differences between the blast and non-penetrating injury groups. Identification of these biochemical changes will give insight into the long-lasting changes associated with head injury, and may identify new targets for treating the associated pathologies.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Traumatic Brain Injury

Interventions

Blood/saliva samplingOTHER

one-time blood sample (\~ 1 TBS) and saliva sample (\~ 1 tsp)

Eligibility

Sex: ALLMin age: 18 YearsMax age: 70 YearsHealthy volunteers:

Medical Language ↔ Plain English

Chronic TBI patients: Inclusion Criteria Have a history of head trauma manifesting in one or more of the following: * Loss of consciousness * Post-traumatic amnesia * Focal neurologic deficits, seizure * Persistent symptoms of increased arousal (e.g. difficulty falling or staying asleep, anger and hypervigilance) * Impairment in social, occupational, or other important areas of functioning (e.g. problems with work and relationships.) Exclusion Criteria Inability to obtain informed consent and if they are non-communicative (i.e. in a vegetative state). Healthy volunteers: Inclusion Criteria * No significant medical history * Take no medications (other than birth control pills) * Fever free * No history of head trauma or recent injury/infection * No history of neurological or psychiatric disorders or alcohol or drug dependency. Exclusion Criteria * Inability to provide informed consent * age/gender match not available in TBI cohort

Outcomes

Primary Outcomes

Proteomic analysis of plasma

The aim is to identify biomarkers in the blood of patients suffering from chronic TBI and to determine the similarities/differences between the blast and non-penetrating injury groups.

Time frame: average of 6 months post injury

Secondary Outcomes

Proteomic analysis of saliva

The aim is to identify biomarkers in the saliva of patients suffering from chronic TBI and to determine the similarities/differences between the blast and non-penetrating injury groups.